Our Team

About

David Madigan, a world-renowned statistician and academic, is a longtime principal investigator for the Observational Medical Outcomes Partnership, forerunner of the observational health data sciences and informatics community now known as OHDSI. He holds a bachelor’s degree in mathematical sciences and a PhD in statistics, both from Trinity College Dublin. 

Madigan has provided expert testimony in legal cases against the drug Vioxx and other hazardous products. Prior to joining Northeastern, Madigan was a professor of statistics at Columbia University, where he chaired the department and served as executive vice president for Arts and Sciences and dean of the Faculty of Arts and Sciences. From 2011 to 2014, he was a member of the FDA’s Drug Safety and Risk Management Advisory Committee. Previously he worked at AT&T Inc., Soliloquy Inc., the University of Washington, Rutgers University, and SkillSoft, Inc. 

As a senior advisor to and principal investigator with the OHDSI Center, Madigan provides scientific oversight and leadership in developing statistical methodologies for generating reliable evidence from large-scale healthcare data. Madigan is credited with more than 200 publications in such areas as Bayesian statistics, text mining, Monte Carlo methods, pharmacovigilance, and probabilistic graphical models. He is an elected fellow of the American Statistical Association, the Institute of Mathematical Statistics, and the American Association for the Advancement of Science. 

Ask him about:

• Bayesian statistics
• developing methods for generating reliable evidence using real-world data